Functional Dyspepsia….An Update

Document Type : Original Article

Authors

1 Department of Internal medicine, Faculty of Medicine, Sohag university.

2 Department of Internal Medicine, Faculty of Medicine, Sohag University Hospital.

Main Subjects

References

  1. Talley NJ, Ford AC. Functional Dyspepsia. N Engl J Med 2015; 373:1853.
  2. Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut 2015; 64: 1049 – 57.
  3. Ford AC, Forman D, Bailey AG et al. Effect of dyspepsia on survival: a longitudinal 10-year follow up study. Am J Gastroenterol 2012; 107: 912 – 21.
  4. Ford AC, Forman D, Bailey AG et al. Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study. Gut 2007; 56: 321 – 7.
  5. Veldhuyzen van Zanten S, Wahlqvist P, Talley NJ et al. Randomized

 

clinical trial: the burden of illness of uninvestigated dyspepsia before and after treatment with esomeprazole—results from the STARS II study. Aliment Pharmacol Ther 2011; 34: 714 – 23.

  1. Lacy BE, Weiser KT, Kennedy AT et al. Functional dyspepsia: the economic impact on patients. Aliment Pharmacol Ther 2013; 38: 170– 7.
  2. Bytzer P, Talley NJ. Dyspepsia. Ann Intern Med 2001; 134:815.
  3. Koch KL, Stern RM. Functional disorders of the stomach. Semin Gastrointest Dis 1996; 7:185.
  4. Malagelada JR. Functional dyspepsia. Insights on mechanisms and management strategies. Gastroenterol Clin North Am 1996; 25:103.
  5.  Stanghellini V, Chan FKL, Hasler WL et al. Gastroduodenal disorders. Gastroenterology 2016; 150: 1380- 92.
  6. Tack J, Talley NJ, Camilleri M et al. Functional gastroduodenal disorders .Gastroenterology 2006; 130: 1466- 79.
  7. Vakil N, Halling K, Ohlsson L et al. Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification. Am J Gastroenterol 2013; 108: 767- 74.
  8.  Vanheel H, Carbone F, Valvekens L, et al. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria. Am J Gastroenterol 2017; 112:132.
  9. Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115:1346.
  10.  Pilichiewicz AN, Horowitz M, Russo A, et al. Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol 2007; 102:1276.
  11.  Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006; 130:296.
  12.  Scolapio JS, Camilleri M. Non-ulcer dyspepsia. Gastroenterologist 1996; 4:13.
  13.  Quartero AO, de Wit NJ, Lodder AC, et al. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci 1998; 43:2028.
  14.  Delgado-Aros S, Camilleri M, Cremonini F, et al. Contributions of gastric volumes and gastric emptying to meal size and post-meal symptoms in functional dyspepsia. Gastroenterology 2004; 127:1685.
  15.  Mearin F, Cucala M, Azpiroz F, Malagelada JR. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991; 101:999.
  16.  Mertz H, Fullerton S, Naliboff B, Mayer EA. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998; 42:814.
  17.  Samsom M, Verhagen MA, vanBerge Henegouwen GP, Smout AJ. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients. Gastroenterology 1999; 116:515.
  18.  Camilleri M, Malagelada JR, Kao PC, Zinsmeister AR. Gastric and autonomic responses to stress in functional dyspepsia. Dig Dis Sci 1986; 31:1169.
  19.  Iovino P, Azpiroz F, Domingo E, Malagelada JR. The sympathetic nervous system modulates perception and reflex responses to gut distention in humans. Gastroenterology 1995; 108:680.
  20.  Van Oudenhove L, Vandenberghe J, Dupont P, et al. Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: an H(2)(15)O-PET study. Am J Gastroenterol 2010; 105: 913.
  21.  Aziz Q, Fass R, Gyawali CP, et al.: Functional Esophageal Disorders. Gastroenterology. 2016; 105(6): 1368–1379. PII: S0016-5085(16)00178-5.
  22.  Quigley EM, Lacy BE: Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol. 2013; 10(3): 175–86.
  23.  Piessevaux H, De Winter B, Louis E, et al.: Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neuro Gastroenterol Motil. 2009; 21(4): 378–88.
  24.  Choung RS, Locke GR 3rd, Schleck CD, et al.: Overlap of dyspepsia and gastroesophageal reflux in the general population: one disease or distinct entities? Neurogastroenterol Motil. 2012; 24(3): 229–34, e106.
  25.  Mearin F, Lacy BE, Chang L, et al.: Bowel Disorders. Gastroenterology. 2016; 150(6): 1393–1407.e5. PII: S0016-5085(16)00222-5.
  26.  Wang A, Liao X, Xiong L, et al.: The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria. BMC Gastroenterol. 2008; 8: 43.
  27.  Futagami S, Yamawaki H, Shimpuku M, et al.: Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia. J Nippon Med Sch. 2013; 80(5): 362–70.
  28.  Piacentino D, Cantarini R, Alfonsi M, et al.: Psychopathological features of irritable bowel syndrome patients with and without functional dyspepsia: a cross-sectional study. BMC Gastroenterol. 2011; 11: 94.
  29.  Ford AC, Marwaha A, Lim A, et al.: Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol. 2010; 8(5): 401- 9.
  30.  Vanheel H, Vicario M, Vanuytsel T, et al.: Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014; 63(2): 262–71.
  31.  Talley NJ: Functional Dyspepsia: Advances in Diagnosis and Therapy. Gut Liver. 2017; 11(3): 349–57.
  32.  Pinto-Sanchez MI, Yuan Y, Bercik P, et al.: Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst Rev. 2017; 3: CD011194.
  33.  Coyle C, Crawford G, Wilkinson J, et al.: Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms. Aliment Pharmacol Ther. 2017; 45(12): 1524–33.
  34.  Thomas E, Wade A, Crawford G, et al.: Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2014; 39(6): 595–602.
  35. Matsushita M, Masaoka T, Suzuki H: Emerging treatments in neurogastroenterology: Acotiamade, a novel treatment option for functional dyspepsia. Neurogastroenterol Motil. 2016; 28(5): 631–8. PubMed Abstract | Publisher Full Text | F1000 Recommendation
  36. 29.  Nakamura K, Tomita T, Oshima T, et al.: A double-blind placebo-controlled study of acotiamide hydrochloride for efficacy on gastrointestinal motility of patients with functional dyspepsia. J Gastroenterol. 2017; 52(5): 602–10. PubMed Abstract | Publisher Full Text
  37.  Matsueda K, Hongo M, Tack J, et al.: A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut. 2012; 61(6): 821–8.
  38.  Kessing BF, Smout AJ, Bennink RJ, et al.: Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects. Neuro Gastroenterol Motil. 2014; 26(8): 1079–86.
  39.  Carbone F, Rotondo A, Andrews CN, et al.: 1077 A Controlled Cross-Over Trial Shows Benefit of Prucalopride for Symptom Control and Gastric Emptying Enhancement in Idiopathic Gastroparesis. Gastroenterology. 2016; 150(4, supplement 1): S213–S214.
  40.  Sáez-González E, Conde I, Díaz-Jaime FC, et al.: Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation. Am J Gastroenterol. 2016; 111(9): 1364–5.
  41.  Suzuki H, Matsuzaki J, Fukushima Y, et al.: Randomized clinical trial: rikkunshito in the treatment of functional dyspepsia--a multicenter, double-blind, randomized, placebo-controlled study. Neurogastroenterol Motil. 2014; 26(7): 950–61.
  42.  Ford AC, Luthra P, Tack J, et al.: Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut. 2017; 66(3): 411–20.
  43.  Talley NJ, Locke GR, Saito YA, et al.: Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 2015; 149(2): 340–9.e2.
  44.  Soo S, Moayyedi P, Deeks J, et al.: Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2005; 2: CD002301.
  45.  Pang B, Jiang T, Du YH, et al.: Acupuncture for Functional Dyspepsia: What Strength Does It Have? A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 2016; 2016: 3862916.
  46.  ACG and CAG Clinical Guideline: Management of Dyspepsia. Am J Gastroenterol, 20 June 2017; DOI: 10.1038/ajg.2017.154

 

Sohag Medical Journal
Volume 23, Issue 2
April 2019
Pages 189-196

Files

Share

How to cite

Statistics